A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors
Clinical trial NCT01004822 · TERMINATED
Trial details
- NCT number
- NCT01004822
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2014-05-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.